Basic Information
ID DDInter1653
Drug Type small molecule
Molecular Formula C13H17N
Molecular Weight 187.286
CAS Number 14611-51-9
Description A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.
ATC Classification N04BD01
IUPAC Name methyl[(2R)-1-phenylpropan-2-yl](prop-2-yn-1-yl)amine
InChI MEZLKOACVSPNER-GFCCVEGCSA-N
Canonical SMILES C[C@H](CC1=CC=CC=C1)N(C)CC#C
Useful Links DrugBank ChEBI PubChem Substance KEGG Compound KEGG Drug ChemSpider BindingDB PharmGKB Therapeutic Targets Database Wikipedia ChEMBL ZINC
Interactions with Selegiline
Filter:
Severity level ID Name Mechanism Detail
Interactions with diseases
Filter:
Severity level Disease name Text References
Interactions with foods
Filter:
Severity level Food name Description Management Mechanism References
Interactions with compound preparation
Multi-DRUG trade Multi-DRUG Drug type Warning Note